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ABSTRACT
The presence of V(IV) in penicillin and cephalosporin solutions, has been shown
previously, in vitro, to promote the degradation of the penicillins and cephalosporins
studied to their corresponding penicilloic and cephalosporanic acids. HPLC studies
provided an additional evidence for the reaction mechanism. The mechanisms
of V(IV) catalysis involve a ternary complex. This work was undertaken to study
the consequences of this degradation, in vivo, upper the pharmacokinetic and
pharmacodynamic of Cefotaxime, being these consequences a lower concentracion
of free cefotaxime in blood, liver, spleen, kidney, lung and heart when there was
intoxication with vanadium. The differences more significant between rats with
vanadium and without it were observed in liver, lung and kidney.
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RESUMEN
Interacción in vivo del Vanadio con Cefotaxima
Anteriormente, en estudios por HPLC, hemos demostrado in vitro, que la pre-
sencia de V (IV) en las disoluciones de penicilinas y cefalosporinas, aumentan la
degradación de éstas en sus correspondientes ácidos penicilóico y cefalosporánico.
Los mecanismos de la catálisis de V (IV) involucran a un complejo ternario. En
este trabajo se estudia las consecuencias de esta degradación, in vivo, de Cefotaxi-
ma, en sangre, hígado, bazo, riñón, pulmón y corazón, para ver las consecuencias
de la intoxicación de vanadio. Las diferencias más importantes en ratas intoxicadas




The transition metal interactions to penicillins (1-5) and
cephalosporins (6) were studied previously by spectrophotometric
and potenciometric methods. In the case of the cefotaxime, as
impurity, also for HPLC (7).
In those studies, it was observed that the effect of V(IV) on the
penicillins and cephalosporins was to promote their degradation to
coordination complexes of V(IV) and the corresponding penicilloic
and cephalosporanic acids (see Figure 1). Other authors have studied
the formation of the complex, in vitro, between V(IV) and penicillins
and cephalosporins, by means of the reaction mechanisms,
evaluating the stability constants for the interaction between V(IV)
and these antibiotics.
This communication presents the way thought which the
formation of the complex between V(IV) and cefotaxime affects on
the concentration, distribution and stability of this cephalosporin.
The importance of the formation of this complex stems from the
lowest concentration of free cefotaxime in blood and organs only
when takes place intoxication. This concentration could be lower
than the concentration of the cephalosporin that is required to kill
the microorganisms that cause the infection.
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FIGURE 1. Mechanism of hydrolytic reaction of the Cefotaxime with addition of
vanadium.
So that we could reach those results, we compared the
concentration, distribution and stability of the free cefotaxime in
rats without toxic with poisoned rats, after 30, 60, 90, 120, 150, 180
and 210 min. after administrating this antibiotic. This comparison
was achieved by measuring the concentration of free cefotaxime
in blood, liver, spleen, kidney, lung and heart homogenates of
poisoned rats and rats without the toxic. The methodology applied
for this purpose was HPLC since this technique facilitates the
separation of the complex V(IV)-cefotaxime, the corresponding
V(IV)-cephalosporanic acid chelate, free cefotaxime and their
compounds resulting from the degradation of cefotaxime.




Seventy five Wistar rats, males of 250 to 300g weight, were used
throughout this work and supplied by the warehouse of the
Complutense University of Madrid.
Animals were maintained in one of the rats room of the
warehouse. The temperature was 20º C, the relative humidity was
55% and the intensity of the light inside the room was 400 LUX
using cycles of 12 hours of light/darkness.
Animals were distributed by groups in order to assay different
treatments. One group of 35 rats with vanadium (group A), which
was poisoned with a nasogastric sound administering to their
everyday 4 mL of a solution of 4 mg/mL of a vanadium (III)
acetylacetonate during 8 days. The groups left were arranged one of
them with 35 rats (group B), and the other one with 5 rats (group C),
both of them without metal.
Groups A and B were put under treatment with an intramuscular
administration of an only dose of 200 mg of cefotaxime.
Group C was used as a control to know the different substances
which belonged to the animals in order to not to be confusing with
the free cefotaxime throughout the study.
Five rats of the groups A and B, were sacrificed after 30, 60, 90,
120, 150, 180 and 210 minutes after the antibiotic administration.
The blood, liver, spleen, kidney, lung and heart of those rats were
extracted and after that, they were measuring their free cefotaxime
concentration by HPLC.
Chemical and Reagents
Cefotaxime sodium was supplied by the Teaching Hospital of
Madrid. Vanadium (III) acetylacetonate was obtained from Merck.
Trichloracetic acid supplied by Scharlau, this substance was used in
concentrations of 10% and 20%.
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The mobile phase reagents used were HPLC grade methanol from
Scharlau. Water used was from a Milli-Rho-Milli-Q system (Millipore,
Bedford, MA, USA). Phosphate buffer (0.1 M) was prepared with
phosphate monopotasic anhydride and o-phosphoric acid supplied
by Merck.
Apparatus and instrument
Kontron high-pressure liquid chromatograph equipped with a
Kontron 420 pump. An automatic injector with 6 valves Kontron
Auto Sampler 460. A variable-wavelength UV detector of Kontron
Uvikon 735 LC. Phenomenex C18 column (25 x 0.46 cm), fulled with
particles of 5 μm, besides this column of separation, a precolumn
and a protective column fulled with the same material that the first
column were used. A Kontron Station Data with D450 software was
used to control the detector and injector, on the other hand it allowed
the integration of the chromatogram peaks and it cuantificated the
results.
ANALYTICAL PROCEDURE
The extraction of cefotaxime in blood was carried out by means
of protein precipitants such as trichloroacetic acid (8) in the
concentration 10%. 1.5 mL of this reagent was added to 0.5 mL of
blood. This mixture was centrifuged at 3000 rpm for 5 min. The
supernatant was collected through a Pasteur pipet and filtered
through MFS disks of nylon of 0.4 mm of diameter. After that, it was
assayed by HPLC.
The extraction of cefotaxime in organs such as liver, spleen,
kidney, lung and heart, was carried out by means of trichloroacetic
acid 20%. 2 mL of this reagent were added to 0.5 g of dry weight
of each organ. Each mixture was done homogeneous and was
centrifuged at 3000 rpm for 10 min. The supernatant was collected
through a Pasteur pipet and filtered through MFS disks of nylon of
0.4 mm of diameter. It was later assayed by HPLC.
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Isocratic HPLC conditions used along this experiment were: the
mobile phase consisted of a 20:80% solution (v/v) of methanol in
0.01 M PO4H2K. The pH of the final solution was adjusted to 3.2 with
phosphoric acid. The flow rate was 1 mL/min. Chromatograph was
loaded with 40 μL of each sample. Chromatograms were run at room
temperature. Samples were detected at 254 nm.
RESULTS AND DISCUSSION
Concentration of cefotaxime
The concentration homogenates of free cefotaxime was measured
in blood, liver, kidney, spleen, lung and heart of the killed rats at
the 30, 60, 90, 120, 150, 180 and 210 min. after the administration
of cefotaxime, those rats were the rats with vanadium and antibiotic
and the rats with cefotaxime only. As there were 5 rats by each time,
the average concentration of free cefotaxime was calculated by each
group of 5 rats that were killed at each time.
TABLE I. Average concentrations (mg/mL) of free cefotaxime in rats without
vanadium
Time (Min)
Samples 30 60 90 120 150 180 210
BLOOD 0.80 0.46 0.25 0.14 0.08 0.06 0.02
LIVER 6.03.10–5 2.68.10–5 2.16.10–5 1.71.10–5 1.42.10–5 1.37.10–5 1.24.10–5
SPLEEN 2.70.10–5 1.58.10–5 1.45.10–5 0.53.10–5 0.41.10–5 0.39.10–5 0.38.10–5
KIDNEY 24.2.10–5 18.1.10–5 10.6.10–5 5.90.10–5 5.01.10–5 4.81.10–5 3.17.10–5
LUNG 7.19.10–5 5.26.10–5 3.52.10–5 3.02.10–5 1.33.10–5 1.22.10–5 0.46.10–5
HEART 2.56.10–5 1.87.10–5 1.23.10–5 1.14.10–5 1.08.10–5 0.86.10–5  0.85.10–5
In blood and in the rest of organs such as liver, spleen, lung,
heart and kidney, we can observe in the Table I that the cefotaxime
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concentration in rats without vanadium is lesser in accordance with
the time that has elapsed since the administration of the antibiotic.
In the Table II, the same case is observed in rats with vanadium, the
greatest cefotaxime concentration is at 30 min. after the administra-
tion of this cephalosporin, and this concentration decreases since
the moment of the administration.
TABLE II. Average concentrations (mg/mL) of free cefotaxime in rats with
vanadium
Time (Min)
Samples 30 60 90 120 150 180 210
BLOOD 0.51 0.25 0.18 0.13 0.12 0.02 0.01
LIVER 4.36.10–5 1.72.10–5 1.41.10–5 1.38.10–5 1.30.10–5 0.32.10–5 0.15.10–5
SPLEEN 1.46.10–5 1.39.10–5 1.38.10–5 0.66.10–5 0.38.10–5 0.37.10–5 0.21.10–5
KIDNEY 20.6.10–5 12.8.10–5 7.58.10–5 5.42.10–5 2.49.10–5 2.38.10–5 1.36.10–5
LUNG 3.86.10–5 2.59.10–5 1.69.10–5 1.59.10–5 1.31.10–5 0.45.10–5 0.23.10–5
HEART 1.88.10–5 1.68.10–5 1.12.10–5 1.11.10–5 1.04.10–5 0.66.10–5 0.29.10–5
Concentrations of cefotaxime, in rats with vanadium and without
it, appeared to decline in a biphasic manner. This decrease in the
cefotaxime concentration happened in the same way that in adults
with a normal renal function (9, 10).
In Table I and II, in all samples of the 2 groups of rats, it could
be noticed two phases in the decrease of cefotaxime concentration.
An initial phase averages 30-90 min. where the concentration
decreased slower.
Cefotaxime concentration does not only change with time, but
also changes in accordance with the intoxication with vanadium.
In rats without vanadium the free cefotaxime concentration
is greater than the concentration in rats with the metal. This fact
happened in blood as well as in the other organs analysed in almost
all times what have been described. The differences more significant
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have been seen in liver, kidney and lung, where there is more
concentration of free cefotaxime in rats without vanadium than
in rats with it. In spleen and heart, those differences were less
significant, although they are very appreciable. In blood,
concentrations of free cefotaxime were greater in rats without
vanadium, but the differences between concentrations are not as
appreciable as in the others samples that have been analysed. So, the
presence of vanadium is an influential factor in the concentration of
free cefotaxime.
This observation has been supported with the help of a statistical
analysis, here the means of concentrations of free cefotaxime, in
blood, liver, spleen, lung, heart and kidney of rats without vanadium
and of the rats with it, at 30, 60, 90, 120, 150, 180 and 210 min.
after administration of this cephalosporin, have been compared.
This comparison has been done by means of a T distribution with
p < 0.05 (Table III).
TABLE III. Differences more significant in concentrations of free cefotaxime
between rats with vanadium and without it
Samples Time (Min) P Value of T
60 0.04 2.40
90 0.02 2.68
BLOOD 180 6.84.10–4 5.35
60 7.78.10–3 3.52
90 0.04 2.44
LIVER 180 5.46.10–6 10.6
210 2.48.10–9 28.5
30 1.37.10–5 9.37
SPLEEN 210 1.37.10–5 6.03
60 0.01 3.24
90 5.27.10–5 7.79
KIDNEY 150 6.11.10–4 5.44
180 1.22.10–5 9.52
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TABLE III. Differences more significant in concentrations of free cefotaxime
between rats with vanadium and without it (cont.)









HEART 180 7.09.10–3 3.58
210 1.16.10–6 12.9
Therefore, in all those times is dismissed the nule hypothesis
and the averages differences of cefotaxime concentrations were
statistically significant. As deduced from these differences between
the free cefotaxime concentration in rats with and without vanadium
did not happen randomly, so those differences in the concentration
could be due to the formation of antibiotic/metal complex, remaining
a lesser concentration of free cefotaxime.
Distribution of cefotaxime
Tables I and II show the greatest concentration of cefotaxime in
blood. In the assayed organs the concentration of this cephalosporin
is decreasing in the sense: kidney > liver > lung > spleen > heart.
Therefore cefotaxime is mainly stored in kidney. This fact is same in
the 2 groups of rats A and B, and because of this, the metal is not
an influential factor in the distribution of cefotaxime.
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Stability of cefotaxime
The decrease rate constants of the concentration of free cefotaxi-
me in rats with vanadium and in rats without it are of first-order,
according to the best values of correlation coefficient. The absolute
values of the logarithmic of the observed constants K are shown in
Table IV, where the highest value of log K is in heart in the 2 groups
of rats, therefore the cefotaxime is more stable in heart than in the
others studied organs.
TABLE IV. The absolute values of the logarithmic of the observed constant K







In rats without vanadium the stability of cefotaxime in organs is
decreasing in the sense: heart and liver > kidney and spleen > lung.
In rats with vanadium the stability is: heart > kidney > liver, spleen
and lung.
In blood it was observed the lowest stability of cefotaxime in the
2 groups of rats.
Therefore in rats that have been or not intoxicated with vanadium
the highest and less stability is at the same site.
It is not only important the presence of vanadium in the
concentration, distribution and stability of cefotaxime, but also the
presence of the metal results to be crucial in the activity of this
cephalosporin because of the decrease of the free cefotaxime
concentration due to the metal.
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If there were a lower concentration of free cefotaxime, it would
not reach the minimum inhibitory concentration to kill the
microorganism that cause the infection, so that the activity of
cefotaxime will decrease or even the cephalosporin will not have
activity in many cases. So, in poisoned patients with vanadium, it is
very important to bear in mind this fact when they have to follow a
course of treatment with cefotaxime.
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